Alopecia Clinical Trials

A listing of Alopecia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 15 clinical trials
Long-Term PF-06651600 for the Treatment of Alopecia Areata

This is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have alopecia

alopecia totalis
androgenic alopecia
areata alopecia
pf-06651600
alopecia universalis
  • 1560 views
  • 13 Jun, 2021
  • 176 locations
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

This is a global Phase 2a randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of ritlecitinib in adults aged 18 to 50 years of age with 25% scalp hair loss

alopecia totalis
areata alopecia
pf-06651600
treatment regimen
alopecia universalis
  • 136 views
  • 13 Jun, 2021
  • 48 locations
Topical Crisaborole in Patients With Alopecia Areata

The aim of this study is to determine whether topical crisaborole improves hair growth in alopecia areata.

methotrexate
corticosteroids
areata alopecia
treatment regimen
minoxidil
  • 114 views
  • 02 Jun, 2021
  • 1 location
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.

ct scan
central pathology review
tumor cells
x-rays
step 2
  • 803 views
  • 07 Jun, 2021
  • 191 locations
Effectiveness of LNS and SBCC to Prevent Stunting Among Children in Afghanistan: a Quasi-experimental Study

Over the years, there has been some progress made in reducing stunting in Afghanistan, the prevalence remains high with half of the provinces experiencing rates above the WHO alert threshold. As part of the Country Strategic Plan (CSP), the World Food Programme (WFP) plans to implement a stunting prevention programme …

  • 0 views
  • 31 May, 2021
  • 1 location
Recovering Damaged Cells for Sequelae Caused by COVID-19 SARS-CoV-2

Post-acute sequelae of SARS-CoV-2 infection can cause multiple system function disorders, and complicated symptoms last for an extended period. The virus can cause this continued infection, or the virus causes immune system function disorder and post-infectious autoimmune disease. The clinical symptoms can be smell loss, taste loss to liver function …

  • 0 views
  • 02 Jun, 2021
  • 1 location
Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata

This was an open-label, Multi-center, randomized phase study. Patients with severe Alopecia Areata were randomized to receive 50mg bid, 150mg qd or 200 mg qd of oral Jaktinib Hydrochloride

alopecia
areata alopecia
  • 235 views
  • 13 Jun, 2021
  • 2 locations
Low Level Light Therapy (LLLT) for Hair Growth

A total of 62 participants will receive red light (660 nm) to the scalp through a specially designed light therapy device integrated into a conventional hat. Each treatment will be 30 min per session applied on every other day for 14 weeks.

low-level laser therapy
photobiomodulation therapy
ludwig
androgenic alopecia
phototherapy
  • 954 views
  • 12 Jun, 2021
  • 1 location
  • 0 views
  • 02 Jun, 2021
  • 27 locations
Tofacitinib for Immune Skin Conditions in Down Syndrome

People with Down syndrome (DS) display widespread immune dysregulation, including several immune skin conditions. This study hypothesizes that pharmacological inhibition of the increased interferon (IFN) signaling seen in DS is safe and could improve associated skin conditions. The study evaluates the safety and efficacy treatment with Tofacitinib, an FDA-approved drug …

unbalanced translocation
interferon
atopy
skin disorder
areata alopecia
  • 52 views
  • 13 Jun, 2021
  • 1 location